QQ客服 官方微博 反馈留言

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文 THORACIC CANCER, 2021 作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan 收藏  |  浏览/下载：65/0  |  提交时间：2022/01/25 advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data   If small molecules immunotherapy comes, can the prime be far behind? 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218 作者:  Zhang, Jingyu;  Zhang, Yu;  Qu, Bingxue;  Yang, Haiyan;  Hu, Shengquan 收藏  |  浏览/下载：65/0  |  提交时间：2021/06/15 Cancer immunotherapy  Small molecule inhibitors  Combination therapy  Tumor microenvironment   Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文 CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936 作者:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan 收藏  |  浏览/下载：17/0  |  提交时间：2021/08/17 Cancer immunotherapy  siRNA delivery  Acid-activatible micelleplex  CDK4  6 inhibitor  PD-L1 knockdown   The ups, downs and new trends of IDO1 inhibitors 期刊论文 BIOORGANIC CHEMISTRY, 2021, 卷号: 110, 页码: 12 作者:  Chen, Shulun;  Tan, Jing;  Zhang, Ao 收藏  |  浏览/下载：14/0  |  提交时间：2021/08/17 Immunotherapy  Cancer  Indoleamine 2,3-dioxygenase  Tryptophan 2,3-dioxygenase  Inhibitors  Checkpoint Inhibitor   Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer 期刊论文 SMALL, 2021, 卷号: 17, 期号: 13, 页码: 11 作者:  Zhu, Qiurong;  Sun, Fang;  Li, Tianliang;  Zhou, Mengxue;  Ye, Jiayi 收藏  |  浏览/下载：108/0  |  提交时间：2021/05/24 colorectal cancer  combinatory immunotherapy  immunogenic cell death  prodrug nanoparticles  second near‐  infrared fluorescence imaging   Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan 收藏  |  浏览/下载：30/0  |  提交时间：2021/03/15 Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer   Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 10 作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan 收藏  |  浏览/下载：44/0  |  提交时间：2021/04/26 breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring   Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer 期刊论文 NANO TODAY, 2021, 卷号: 36, 页码: 12 作者:  Zhou, Fengqi;  Gao, Jing;  Xu, Zhiai;  Li, Tianliang;  Gao, Ang 收藏  |  浏览/下载：25/0  |  提交时间：2021/06/11 Tumor microenvironment  Prodrug nanovesicles  Cancer immunotherapy  Immunogenic cell death  Adaptive immune resistance   Fractionated regimen-suitable immunoradiotherapy sensitizer based on ultrasmall Fe4Se2W18 nanoclusters enable tumor-specific radiosensitization augment and antitumor immunity boost 期刊论文 NANO TODAY, 2021, 卷号: 36, 页码: 13 作者:  Zhou, Ruyi;  Yan, Liang;  Dong, Xinghua;  Zhu, Shuang;  Chen, Kui 收藏  |  浏览/下载：20/0  |  提交时间：2021/08/31 Immunoradiotherapy  Abscopal effect  Fractionated regimen  Sandwich-type polyoxotungstate  Fenton reaction  Oxidative stress   Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis 期刊论文 CANCER MEDICINE, 2021, 页码: 19 作者:  Geng, Yichao;  Zhang, Qiuning;  Feng, Shuangwu;  Li, Chengcheng;  Wang, Lina 收藏  |  浏览/下载：27/0  |  提交时间：2021/12/10 combined radio-immunotherapy  meta-analysis  non-small-cell lung cancer  programmed cell death protein-1/programmed cell death ligand-1 inhibitors  radiotherapy  systematic review